President Donald Trump's nominee to lead the Food and Drug Administration (FDA) Dr. Marty Makary passed a key committee vote ...

process Special Report: Imricor Medical Systems has announced another key milestone towards US regulatory approval for its ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...

After the contentious Senate confirmation of Robert F. Kennedy Jr., another crucial governmental health leadership ...

Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.

Here are three key takeaways from the hearing ... you have my commitment to come to follow the independent scientific review process at the FDA, which is a tried-and-true process and that has ...

Loyal’s CEO, Celine Halioua, estimates that the process should be complete by the end of 2025 and called the FDA’s initial recognition “a key step” to extending dogs’ lives. The Center ...

which are undergoing the US Food and Drug Administration’s (FDA’s) premarket approval (PMA) process, with an additional third-party product it will distribute. The company said the second ...

Imricor has achieved another key milestone with the second module ... Imricor is executing a modular review process with the FDA, whereby modules covering various aspects of the company’s ...